Ormeloxifene nanotherapy for cervical cancer treatment

BACKGROUND: Cervical cancer (CxCa) ranks as the fourth most prevalent women-related cancer worldwide. Therefore, there is a crucial need to develop newer treatment modalities. Ormeloxifene (ORM) is a non-steroidal, selective estrogen receptor modulator (SERM) that is used as an oral contraceptive in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Nanomedicine
Autors principals: Chauhan, Neeraj, Maher, Diane M, Hafeez, Bilal B, Mandil, Hassan, Singh, Man M, Yallapu, Murali M, Jaggi, Meena, Chauhan, Subhash C
Format: Artigo
Idioma:Inglês
Publicat: Dove 2019
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6731961/
https://ncbi.nlm.nih.gov/pubmed/31564868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S200944
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars